✦ LIBER ✦
Weekly ixabepilone with or without concurrent bevacizumab in the treatment of platinum/taxane-resistant endometrial and ovarian cancers: An institutional experience
✍ Scribed by Roque, D.M.; Schwab, C.L.; English, D.P.; Ratner, E.S.; Silasi, D.A.; Azodi, M.; Rutherford, T.J.; Schwartz, P.E.; Santin, A.
- Book ID
- 126995012
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 151 KB
- Volume
- 133
- Category
- Article
- ISSN
- 0090-8258
No coin nor oath required. For personal study only.